ClinicalTrials.gg
CompletedNCT07800130TRX-INTUpdated Sep 28, 2026

TRX Training Intensity in Male Adolescent Basketball Players

An interventional study of TRX Suspension Training in Physical Fitness, Basketball and Resistance Training, sponsored by Uludag University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 15 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by Uludag University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 2 years 1 month after the study started (first participant enrolled Jul 2024, registered Aug 2026).
Updated Sep 28, 2026Enrollment updatedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
15 Years to 17 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 995 studies in Motor Activity with a site in Turkey — 196 open to participants now, 225 under way, none of them phase 3. Motor Activity · Turkey.

Enrollment
340th of 768
45 · median 42
Started
2024
with 147 others
No phase
768 of 995
160 open now
Registered
961st of 995
by date

Among the 995 studies in Motor Activity with a site in Turkey, this one is the 340th largest by enrollment of the 768 interventional ones that give a count, is one of 148 that started in 2024, is one of 768 with no phase, and was the 961st registered.

Motor Activity

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

Browse Motor Activity studies →

Open to participants now

196 of the 995 studies in Motor Activity with a site in Turkey are open now. Recruiting first, the newest first:

191 more — sign in →

All 196 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,201 Motor Activity studies recruiting now, 517 (43%) set no upper age limit and 535 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 15 Years to 17 Years · male · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 995 studies in Motor Activity with a site in Turkey, or all of them as a file.
02

Study summary

This randomized interventional study aims to compare the effects of low-, moderate-, and high-intensity TRX suspension training on physical performance in male adolescent basketball players. Forty-two athletes aged 15 to 17 years are assigned to one of three TRX training intensity groups and complete an 8-week supervised training program in addition to their regular basketball practice. Outcomes are assessed before and after the intervention and include agility, dual-task agility, balance, upper-extremity muscular endurance, and rating of perceived exertion (RPE). The study seeks to determine whether different TRX training intensities produce distinct adaptations in these performance outcomes and to provide evidence for optimizing suspension-training prescription in youth basketball players.

Read the detailed description

Basketball performance depends on agility, balance, neuromuscular coordination, and the ability to perform motor tasks under cognitive demands. TRX suspension training has become increasingly popular in athletic conditioning because it challenges trunk stability, body control, and functional movement patterns. However, limited evidence is available regarding whether different TRX training intensities produce distinct adaptations in adolescent basketball players.

This randomized, three-arm interventional study compares the effects of low-, moderate-, and high-intensity TRX suspension training performed over an 8-week period in male adolescent basketball players. Training is conducted three times per week in addition to regular basketball practice. Internal training intensity is prescribed using heart-rate reserve (HRR) zones and monitored throughout the intervention.

The study evaluates changes in agility, dual-task agility, balance, upper-extremity muscular endurance, and perceived exertion. The primary objective is to determine whether prescribing different TRX training intensities results in different neuromuscular and performance adaptations in adolescent basketball players. The findings are expected to contribute to evidence-based recommendations for the prescription of suspension training in youth basketball conditioning programs.

03

Conditions studied

  • Physical Fitness
  • Basketball
  • Resistance Training
  • Exercise

Browse trials for

Keywords

  • TRX suspension training
  • Suspension training
  • Basketball
  • Adolescent athletes
  • Resistance training
  • Agility
  • Dual-task performance
  • Balance
  • Muscular endurance
  • Heart rate reserve
  • Training intensity
  • Youth athletes
  • Exercise
04

Who can participate

Ages eligible
15 Years to 17 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male basketball players aged 15 to 17 years.
  • Active participation in organized basketball training and competition.
  • At least 6 years of regular basketball training experience.
  • Participation in basketball training at least 5 days per week.
  • Written from a parent or legal guardian and assent from the participant.

Exclusion criteria

Exclusion Criteria:

  • Serious lower-extremity injury within the previous 6 months.
  • Diagnosed neurological or orthopedic condition limiting training or testing.
  • Failure to complete the intervention protocol.
  • Missing required pre- or post-intervention assessments.
  • Incomplete testing records.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
45 participants (actual)

Study arms

  • Experimental
    LI-TRX

    Participants performed an 8-week supervised TRX suspension training program at 45-60% heart rate reserve (HRR), three sessions per week, in addition to regular basketball training.

    Behavioral: TRX Suspension Training

  • Experimental
    MI-TRX

    Participants performed an 8-week supervised TRX suspension training program at 65-75% heart rate reserve (HRR), three sessions per week, in addition to regular basketball training.

    Behavioral: TRX Suspension Training

  • Experimental
    HI-TRX

    Participants performed an 8-week supervised TRX suspension training program at 80-95% heart rate reserve (HRR), three sessions per week, in addition to regular basketball training.

    Behavioral: TRX Suspension Training

Interventions

  • BehavioralTRX Suspension Training

    Participants completed an 8-week supervised TRX suspension training program performed three times per week in addition to their regular basketball training. All groups completed the same exercises, session frequency, session duration, training volume, and supervision. The intervention included TRX Side Bend, Knee Pull, T-Jump, Squat Jump, Mountain Climber, Superman, Sumo Squat Jump, Single-Leg Squat, Side Squat, and Hamstring Curl. The only difference between groups was the prescribed internal training intensity based on heart rate reserve (HRR): 45-60% (LI-TRX), 65-75% (MI-TRX), or 80-95% (HI-TRX).

06

What researchers measure

Primary outcomes

  1. Agility Performance

    Agility performance assessed using the Illinois Agility Test. Completion time was recorded in seconds using electronic timing gates. Lower values indicate better performance.

    Time frame: Baseline and immediately after the 8-week intervention

Secondary outcomes

  1. Dual-task Agility Performance

    Dual-task agility assessed as completion time during the Illinois Agility Test performed concurrently with a verbal cognitive task. Lower values indicate better performance.

    Time frame: Baseline and immediately after the 8-week intervention

  2. Balance Performance

    Balance performance assessed using a stabilometric balance platform. Lower scores indicate better balance control.

    Time frame: Baseline and immediately after the 8-week intervention

  3. Upper-extremity Muscular Endurance

    Upper-extremity muscular endurance assessed using the 30-second push-up test. Higher values indicate better performance.

    Time frame: Baseline and immediately after the 8-week intervention

  4. Rating of Perceived Exertion (RPE)

    Perceived exertion assessed using the Borg CR-10 scale.

    Time frame: Baseline and immediately after the 8-week intervention

07

Study locations

1 site
  • Bursa Uludag University
    Bursa, 16000, Turkey (Türkiye)
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) underlying the results reported in this study, including participant characteristics and outcome measure data, will be made available to qualified researchers upon reasonable request to the corresponding author. Data sharing will be subject to institutional policies, ethical approval, and applicable data protection regulations.

Supporting information: Study protocol

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2024 to primary completion in Sep 2024, 2 months.

Of 5,147 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 2 months is below that.

Counting every sponsor, half of 5,207 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2026
First posted
Sep 2, 2026
StartActual
Jul 15, 2024
Primary completionActual
Sep 30, 2024
CompletionActual
Sep 30, 2024
Last update
Sep 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Enrollment
42→45
Sep 28, 2026
Show all 1 update
  1. Sep 28, 2026
    Enrollment 42→45

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07800130
Lead sponsor
Uludag University
Responsible party
Mertkan Öncü (MsC, Uludag University) — Principal investigator
First posted
Sep 2, 2026
Start date
Jul 15, 2024
Primary completion
Sep 30, 2024
Completion
Sep 30, 2024
Last update
Sep 28, 2026

Study contacts

Sadettin Erol, PhD
study chair · Uludag University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion